In Brief: Ivax
This article was originally published in The Tan Sheet
Executive Summary
Ivax: Rx-to OTC switch area "has our very keen interest," Ivax President John Klein told a recent conference for securities analysts in New York City. The generic drug firm estimated there are 57 products with a "high probability" of being switch candidates...